Is Anduril overvalued at $61B?
In our defense tech market deck, you will find everything you need to understand the market
SUMMARY
Anduril may be overvalued at $61B if judged like a normal defense contractor, but the valuation becomes more defensible if the company keeps doubling revenue and proves it can manufacture autonomous systems at scale.
The latest valuation is $61B, after a $5B Series H announced on May 13, 2026. That doubled Anduril’s previous $30.5B valuation in 342 days.
The valuation jump was not Anduril’s biggest in percentage terms, but it was the biggest in dollars. The company added $30.5B of value in less than a year, which is as much as the whole company was worth after its prior round.
Anduril’s valuation growth is extreme for defense, but not extreme versus the most violent tech re-ratings. Its latest jump added about $2.7B per month, far below the reported valuation acceleration of SpaceX, OpenAI, or Tesla during their biggest runs.
The main valuation problem is revenue multiple. At $61B and roughly $2.2B of 2025 revenue, Anduril is valued at about 27.7x revenue.
That is far above legacy defense primes. Lockheed Martin, RTX, Northrop Grumman, and Boeing mostly trade around 1.6x to 2.7x revenue, making Anduril’s multiple roughly 14x higher than the simple average of those companies.
Anduril is not alone in this new valuation regime. Shield AI, Saronic, Skydio, and Palantir show that investors are willing to pay tech-style multiples for companies tied to autonomy, drones, maritime systems, and defense AI.
The valuation is not crazy if revenue keeps doubling. Anduril reportedly grew from about $500M in 2023 revenue to roughly $1B in 2024 and about $2.2B in 2025, implying around 110% annualized growth over that period.
The catch-up math is demanding. At a $61B valuation, Anduril would need about $24B in annual revenue to trade at a mature defense multiple of 2.5x revenue, which is roughly 11x its 2025 revenue.
The biggest risk is not demand. The demand signals are strong, but Anduril still has to convert contracts, facilities, and battlefield demand into delivered systems, recognized revenue, and margins good enough to justify a tech-style multiple.
Manufacturing scale is the key proof point. Anduril has real products, real contracts, and real production facilities, but it has not yet proven it can produce tens of thousands of autonomous defense systems per year reliably and cheaply.
The conclusion is that Anduril is expensive, but not obviously irrational. At $61B, investors are not valuing today’s company. They are valuing a future defense platform that becomes a $10B-plus revenue company quickly, keeps compounding, and proves that software-native defense manufacturing can scale.
This market map, featured in our defense tech market deck, highlights top companies and startups in the defense tech market
What is Anduril worth today? How much did it jump?
Anduril’s latest valuation is $61 billion, after a $5 billion Series H announced on May 13, 2026. That is the number we should use today.
Before the $61 billion valuation, Anduril was valued at $30.5 billion in June 2025, after a $2.5 billion Series G. So the latest round doubled the company’s valuation in 342 days.
The jump was exactly +$30.5 billion, or +100%, in less than a year.
So, Anduril added as much value in 11 months as the entire company was worth after its previous round.
Did Anduril ever jump this much before?
Yes, but not at this dollar scale. Anduril had already more than doubled before, but the latest jump is different because the company doubled from an already huge base.
Here is the clean chronology. In August 2024, Anduril was valued at $14 billion after a $1.5 billion Series F. In June 2025, it reached $30.5 billion after a $2.5 billion Series G. In May 2026, it reached $61 billion after a $5 billion Series H.
So the first big jump was from $14 billion to $30.5 billion. That was +$16.5 billion, or +118%, in about 10 months. The second big jump was from $30.5 billion to $61 billion. That was +$30.5 billion, or +100%, in 342 days.
The percentage jump was actually slightly bigger in the previous round: +118% versus +100%. But the latest jump was much bigger in absolute dollars: +$30.5 billion versus +$16.5 billion.
So, Anduril has now had two consecutive “doubling-like” rounds, but the second one is more meaningful. Doubling from $14 billion is impressive. Doubling from $30.5 billion is a different signal. It means private investors are starting to price it as one of the few companies that could structurally change the defense industry.
| Date / round | Valuation | Jump vs previous valuation | Time since previous round |
|---|---|---|---|
| Aug. 2024 / Series F | $14B | — | — |
| Jun. 5, 2025 / Series G | $30.5B | +$16.5B / +118% | ~302 days |
| May 13, 2026 / Series H | $61B | +$30.5B / +100% | 342 days |
As this chart shows, and as featured in our defense tech market deck, search interest in defense tech has risen sharply
Did Anduril add valuation faster than the biggest tech winners?
Anduril’s valuation growth is extreme, but it is not the fastest we have seen.
Let’s do some math and focus on one metric: the valuation added per month.
For Anduril’s latest jump, the math is simple: it’s about +$2.7 billion of valuation added per month.
So yes, Anduril accelerated. But compared with the most violent tech re-ratings, Anduril is not in the same league yet.
For example, SpaceX reportedly went from $210B in June 2024 to $350B in December 2024: +$140B in six months, or about +$23B/month. That is roughly 8.5x Anduril’s latest pace of +$2.7B/month.
OpenAI went from $157B in October 2024 to $300B in March 2025: +$143B in about six months, or roughly +$24B/month. That is about 8.9x Anduril’s pace.
Tesla’s 2020 run was even more violent. Its market cap went from roughly $76B at the end of 2019 to $677B at the end of 2020: +$601B in one year, or about +$50B/month. That is roughly 18.5x Anduril’s pace.
So Anduril’s jump is huge, but not top-tier by absolute tech re-rating standards. The real point is sector-specific: adding +$2.7B/month is extraordinary for defense, where new entrants almost never compound value this quickly.
If you want more recent data on this point, please see our latest defense tech market report.
Is Anduril expensive compared with its revenue?
Yes, since Anduril is valued at about 28x revenue, based on its latest reported $61B valuation and roughly $2.2B in 2025 revenue.
That revenue number is recent enough to use. It was reported around the May 2026 Series H, so we are not comparing the new valuation against stale 2023 or early-2024 revenue. The simple math is: $61B / $2.2B = 27.7x revenue.
That is a very high multiple. It means investors are not valuing Anduril like a normal defense contractor but like a high-growth strategic platform.
Also, we have to note that Anduril reportedly doubled revenue to $2.2B in 2025, so the market is paying for speed. But even with that growth, 28x revenue is aggressive.
This chart, included in our defense tech market deck, shows annual VC investment in defense tech startups
How does Anduril’s revenue multiple compare with Lockheed, RTX, Northrop, and Boeing?
The gap is huge. Traditional aerospace and defense primes mostly trade around 1.6x to 2.7x revenue. Anduril is at 27.7x.
| Company | Market cap / valuation | Latest revenue used | Revenue multiple |
|---|---|---|---|
| Anduril | $61B valuation | ~$2.2B 2025 revenue | ~27.7x |
| Lockheed Martin | ~$120.8B market cap | ~$75.1B TTM revenue | ~1.6x |
| RTX | ~$243.7B market cap | ~$90.4B TTM revenue | ~2.7x |
| Northrop Grumman | ~$77.6B market cap | ~$42.4B TTM revenue | ~1.8x |
| Boeing | ~$169.8B market cap | ~$92.2B TTM revenue | ~1.8x |
So Anduril is valued at roughly 17x Lockheed’s revenue multiple, 10x RTX’s, 15x Northrop’s, and 15x Boeing’s.
Against the simple average of those four companies, Anduril’s multiple is about 14x higher.
That is the clean comparison. Legacy defense companies are valued like mature industrial businesses: large revenue bases, slower growth, heavy execution risk, and limited margin expansion.
Is Anduril the only defense startup valued this aggressively?
No. Anduril is not an isolated case. The broader pattern is that investors are repricing a small group of “new defense” companies at tech-style revenue multiples, not legacy defense multiples.
Anduril is still the largest private defense-tech case. As seen before, at a $61B valuation and roughly $2.2B in 2025 revenue, it is valued at about 27.7x revenue. That is already far above Lockheed, RTX, Northrop, or Boeing, which mostly trade around 1.6x to 2.7x revenue.
But when we compare Anduril with other defense-tech disruptors, the picture changes. Its multiple is high, but not obviously insane inside the new defense-tech basket.
| Company | What it disrupts | Latest valuation used | Revenue used | Valuation / revenue | Vs Anduril’s multiple |
|---|---|---|---|---|---|
| Anduril | Autonomous defense systems, drones, AI command software | $61B | ~$2.2B | ~27.7x | 1.0x |
| Shield AI | Autonomous AI pilots and military aircraft autonomy | ~$12.7B | ~$400M | ~31.8x | ~1.1x higher |
| Saronic | Autonomous naval vessels | ~$9.25B | ~$200M–$400M | ~23x–46x | ~0.8x–1.7x Anduril |
| Skydio | U.S.-made drones for defense and public-sector buyers | ~$4.4B | ~$295M | ~14.9x | ~0.5x Anduril |
| Palantir | Defense and government AI software, now public | ~$348B market cap | ~$5.22B TTM revenue | ~66.7x | ~2.4x higher |
The cleanest private comparison is Shield AI. If we use its reported $12.7B valuation and $400M 2025 revenue, Shield AI is valued at about 31.8x revenue, slightly above Anduril’s 27.7x.
That tells us Anduril is not the only company getting a premium multiple for defense autonomy.
Saronic is also relevant, but noisier. It was reportedly valued at $9.25B in 2026. Depending on whether we use the lower $200M 2025 revenue estimate or the higher $400M revenue figure cited in other datasets, Saronic trades at roughly 23x to 46x revenue. The range is wide, but the message is the same: investors are willing to pay Anduril-like or higher multiples for companies attacking defense bottlenecks with autonomous hardware.
Skydio looks less extreme. Using a reported $4.4B valuation and around $295M in 2025 ARR, it trades around 15x revenue. That is still far above legacy defense primes, but meaningfully below Anduril. The likely reason is simple: Skydio is a strong drone company, but Anduril is being priced as a broader defense platform.
Palantir is the public-market exception. It is not a pure defense contractor, but it is the most relevant public “defense AI” comp. At roughly $348B market cap and $5.22B in trailing revenue, it trades around 66.7x revenue, about 2.4x Anduril’s multiple. We wanted to look at this data because it shows public markets can validate extremely high multiples when investors believe the company owns a strategic AI layer.
So, clearly, Anduril is not alone. The new defense-tech market has created a separate valuation regime.
If you want more recent data on this point, please see our latest defense tech market report.
This chart, included in our defense tech market deck, shows why Anduril is winning in defense tech
Is Anduril’s revenue growing fast enough to justify its valuation?
The valuation is not crazy if Anduril keeps doubling revenue. It becomes crazy if growth slows too early.
The growth is the reason investors can even try to justify that number. Anduril reportedly did around $500M in 2023 revenue, roughly $1B in 2024, and about $2.2B in 2025. That means revenue roughly doubled in 2024, then more than doubled again in 2025. From 2023 to 2025, revenue grew about 4.4x, which implies roughly 110% annualized growth.
Monthly, that is also very fast. Going from $1B in 2024 to $2.2B in 2025 implies about 6.8% compounded monthly revenue growth. That is the right way to frame the acceleration: Anduril is not just growing 20-30% like a mature defense contractor. It is still growing like a venture-backed platform company.
We can sanity check all of this.
As seen above, at $61B, Anduril is valued at 27.7x 2025 revenue. If revenue reaches the reported $4.3B 2026 projection, the multiple drops to about 14.2x forward revenue.
If it doubles again to around $8.6B, the multiple drops to about 7.1x. So Anduril does not need one good year to grow into the valuation. It needs at least two more major revenue steps.
That is the real answer.
How quickly can Anduril’s revenue catch up to valuation?
At the current $61B valuation, Anduril would need about $24B in annual revenue to trade at a mature defense multiple of 2.5x revenue. That is roughly 11x its 2025 revenue. It is a huge gap.
But if Anduril keeps growing at around 100% per year, that gap closes surprisingly fast. Revenue would go from $2.2B to roughly $4.4B, then $8.8B, then $17.6B, then $35B. In that scenario, the current valuation starts to look much more reasonable by the late 2020s.
Anduril’s valuation is not pricing today’s company but a version of Anduril that becomes a $10B-plus revenue company very quickly, then keeps compounding inside U.S. and allied defense budgets.
If you want more recent data on this point, please see our latest defense tech market report.
This chart, included in our defense tech market deck, shows annual funding in defense tech startups
What do analysts think of Anduril’s current valuation?
Credible market signals suggest the valuation is aggressive, but not random.
The clearest argument came from Forbes, which framed the $61B valuation as a bet on faster Pentagon procurement. At roughly 28x 2025 revenue, Anduril looks expensive versus Lockheed at around 1.6x revenue. But the bet is that defense spending shifts toward autonomy, drones, AI command software, and faster manufacturing.
The strongest signal came from the secondary market. Business Insider reported that some investors were willing to pay up to a 40% premium above the roughly $60B round price to buy Anduril shares. That implies demand closer to an $84B valuation. Greg Martin of Rainmaker Securities called the premium “unusual,” because secondary premiums are usually more like 5% to 15%.
Sacra gives the sanity check. It estimates Anduril at about $2.1B–$2.2B in 2025 revenue, with a projected jump to roughly $4.3B in 2026, but also around $1.2B in projected 2026 operating losses. So the bull case is real growth, the bear case is execution risk.
Is Anduril profitable yet? Do we know its margins?
Anduril does not look profitable today. The best available data says it is still in investment mode: fast revenue growth, heavy R&D, heavy manufacturing buildout, and meaningful operating losses.
The clearest number we found is Sacra’s estimate that Anduril is projecting about $4.3B in 2026 revenue and roughly $1.2B in operating losses. That implies an operating margin of about -28% for 2026. So even if revenue nearly doubles again, the company is still expected to lose a lot of money.
That does not mean the business is broken. It means Anduril is spending ahead of revenue recognition. Defense hardware is not pure software: the company has to build factories, fund R&D, manufacture systems, and deliver against long government contracts. The losses are therefore not surprising. But they matter because a $61B valuation gives Anduril very little room for execution mistakes.
On gross margins, the picture is less official. Anduril is private, so we do not have audited public gross margin disclosures. Some market sources estimate gross margins around 40-45%, which would be much higher than traditional defense primes and closer to a software-enabled hardware model. But we should treat that as an estimate, not a confirmed company-reported number.
This chart, included in our defense tech market deck, compares the main business model options for defense AI contractors
What could still go wrong for Anduril?
Anduril’s valuation is not crazy, but the risk list is real.
At $61B, the company has to prove it can turn defense-tech hype into repeatable revenue, scalable manufacturing, and eventually profit.
| Risk | Why it matters | What we need to see |
|---|---|---|
| Profitability | Anduril is still likely loss-making. Sacra estimates about $4.3B in 2026 revenue but roughly $1.2B in operating losses, implying around -28% operating margin. | Losses must shrink as revenue scales, not grow with it. |
| Manufacturing scale | Anduril is building Arsenal-1 in Ohio to mass-produce drones and autonomous systems. That is the core bull case, but also the biggest execution test. | On-time production, lower unit costs, and no major quality issues. |
| Contract conversion | A big contract ceiling is not the same as revenue. For example, a $20B Army framework is a maximum potential value, not guaranteed sales. | Funded orders, deliveries, renewals, and repeat procurement. |
| Margin quality | Estimated gross margins around 40-45% sound attractive, but they are not official audited disclosures. Defense hardware can get squeezed by fixed-price contracts. | Clear evidence that hardware plus software can sustain premium margins. |
| Valuation pressure | At $61B and about $2.2B in 2025 revenue, Anduril is valued around 28x revenue. That only works if growth stays very high. | Revenue needs to keep doubling or near-doubling for several years. |
| Procurement speed | The bull case assumes the Pentagon buys faster and shifts toward autonomy, drones, and AI systems. That is not guaranteed. | Faster budget cycles, larger production orders, and allied adoption. |
| Platform breadth | Anduril is valued like a future defense platform, not a single-product company. That requires winning across air, land, sea, space, and command software. | More large programs where Anduril is embedded, not just selected. |
The biggest risk is not demand. The demand signal is clearly there. The bigger risk for Anduril today is industrial translation: can Anduril convert demand into delivered systems, recognized revenue, and margins good enough to justify a tech-style multiple?
If you want more recent data on this point, please see our latest defense tech market report.
Has Anduril actually proven it can manufacture at scale?
Not fully. Anduril has proven it can build real products, win real contracts, and stand up production infrastructure. But it has not yet proven the most important claim in its valuation: that it can manufacture autonomous defense systems at massive scale, reliably and cheaply.
| Manufacturing claim | Proven or speculative? | What we know |
|---|---|---|
| Anduril can build working defense systems | Proven | The company already sells drones, counter-drone systems, autonomous underwater vehicles, sensors, and Lattice software. This is not a prototype-only company. |
| Anduril has real production facilities | Proven | It has announced Arsenal-1 in Ohio, a roughly 5M-square-foot manufacturing campus, plus a Rhode Island facility for Dive-LD autonomous underwater vehicles. |
| Anduril can win demand for manufactured systems | Proven | It has major government demand signals, including Navy Dive-LD work and a large Army framework contract for counter-drone and command-and-control systems. |
| Anduril can produce some systems at meaningful volume | Partly proven | The Rhode Island AUV facility was announced with capacity for up to 200 autonomous underwater vehicles per year. That is real scale, but not yet “hyperscale.” |
| Arsenal-1 can produce tens of thousands of systems per year | Still speculative | Anduril says Arsenal-1 is designed for tens of thousands of autonomous systems annually. That is a target capacity, not yet a proven output record. |
| Anduril can manufacture like an automotive-style defense factory | Still speculative | This is the core bull case. We need evidence of repeatable throughput, quality control, lower unit costs, and on-time delivery across multiple product lines. |
| Anduril can scale without killing margins | Still speculative | Estimated gross margins may be attractive, but official margins are not public, and scaling hardware production can expose cost overruns fast. |
This chart, featured in our defense tech market deck, shows the share of revenue generated by each customer segment in the defense tech market
Are investors overhyping Anduril because of Ukraine, drones, and AI?
Yes, there is hype. But it is hype built on real data, not pure fantasy.
The strongest evidence is Ukraine. The war turned drones from a niche defense category into a mass-consumption battlefield product. Ukraine reportedly produced about 1.8M drones in 2024, then talked about capacity for roughly 4M drones per year by 2025. FPV drone output alone reportedly moved from around 20,000 per month in 2024 to about 200,000 per month in 2025.
That is the core reason investors changed their minds: drones stopped looking like expensive specialty systems and started looking like artillery-scale consumables.
The second evidence point is capital flow. Aerospace and defense startups reportedly raised more than $19B in 2025, almost double the prior year’s $10B. That tells us Anduril is not an isolated mania. The whole category is being repriced around drones, autonomy, AI, space, sensors, and faster procurement.
The third evidence point is the Pentagon demand. The U.S. launched Replicator to field thousands of attritable autonomous systems across multiple domains. That validates the direction of travel. But Replicator also shows the risk: the Pentagon has struggled to deploy AI-enabled weapons quickly, with delays, integration issues, unreliable systems, and procurement friction. So demand is real, but conversion is not automatic.
That is the right balance. The bull case is backed by hard signals: millions of drones in Ukraine, billions of VC dollars, and U.S. programs explicitly trying to buy autonomous systems at scale.
The bear case is also backed by hard signals: defense procurement remains slow, battlefield tech commoditizes fast, and scaling reliable hardware is harder than scaling software.
Is Anduril really the next Palantir?
No. Anduril is Palantir-like in customer, narrative, and strategic importance, but it is not the same business. Palantir became a software layer for government data and decision-making. Anduril is trying to become something broader: a software-native defense prime that sells the brain, the hardware, and the factory.
Anduril goes beyond dashboards and analytics. It sells drones, counter-drone systems, autonomous underwater vehicles, sensors, missiles, and Lattice, its command-and-control platform.
Anduril is not the next Palantir. It is a more industrial, higher-risk version of the same strategic idea. If it works, it becomes one of the defining defense companies of the next decade. If it fails, it will fail for a very un-Palantir reason: not because the software layer was irrelevant, but because scaling autonomous defense hardware is brutally harder than selling software into government.
If you want more recent data on this point, please see our latest defense tech market report.
This chart, included in our defense tech market deck, shows how tactical networking platform technology has evolved over time
OUR METHODOLOGY
This analysis tests whether Anduril’s $61 billion valuation is economically plausible based on the evidence available today. We compare the headline valuation with Anduril’s latest financing round, previous private-market valuations, reported revenue growth, operating-loss estimates, comparable defense-tech multiples, legacy defense multiples, contract momentum, and manufacturing scale.
When we refer to Anduril’s “$61 billion valuation,” we mean the valuation attached to the reported May 2026 Series H financing unless we explicitly say otherwise. That number is treated as the current private-market valuation, not as a public-market trading price.
We treat Anduril’s prior funding rounds as the cleanest valuation chronology because they give dated valuation marks: the $14 billion Series F in August 2024, the $30.5 billion Series G in June 2025, and the $61 billion Series H in May 2026.
For revenue multiples, we use Anduril’s reported 2025 revenue estimate of roughly $2.2 billion as the baseline. We then compare the resulting valuation-to-revenue multiple with legacy defense primes and with high-growth defense-tech or defense-adjacent companies.
For the legacy defense comparison, we use current market-cap and trailing-revenue references for Lockheed Martin, RTX, Northrop Grumman, and Boeing. The goal is not to say Anduril should trade exactly like those companies, but to show how far its valuation sits above mature aerospace and defense norms.
For the defense-tech comparison, we looked at companies in autonomy, drones, maritime systems, and defense AI. This helps separate the Anduril-specific question from the broader market repricing of new defense companies.
For profitability and margin quality, we use recent credible reported estimates rather than audited public-company disclosures, because Anduril is still private. We therefore treat operating-loss and gross-margin figures as directional, not definitive.
For manufacturing scale, we separate what is already evidenced from what is still a target. Products, contracts, announced facilities, and stated capacity are real signals. But mass-producing tens of thousands of autonomous defense systems per year is still something Anduril has to prove operationally.
For the risk section, we focus on the pressure points that matter most to whether Anduril can grow into a $61 billion valuation: revenue conversion, operating losses, manufacturing scale, contract execution, procurement speed, margin quality, and platform breadth.
For Ukraine, drones, and AI hype, we looked for concrete signals: battlefield drone volumes, public defense programs, VC funding, and procurement shifts. The goal was to separate narrative hype from market changes supported by visible data.
We prioritized sources that added specific, checkable information: valuation, raise size, revenue, manufacturing capacity, contract frameworks, defense procurement programs, startup funding, comparable-company valuations, and comparable-company revenue. We excluded commentary that repeated the valuation headline without adding evidence.
Key sources used for this analysis include: Anduril on its $5 billion Series H and $61 billion valuation, TechCrunch on Anduril’s $30.5 billion Series G valuation, Anduril on its $1.5 billion Series F and Arsenal push, Anduril’s Arsenal-1 manufacturing page, Anduril on its Rhode Island autonomous underwater vehicle production facility, the U.S. Army on its enterprise contract award, DIU on the Department of Defense Replicator initiative, PitchBook’s 2025 defense-tech snapshot, Shield AI on its $12.7 billion valuation, Saronic on its $9.25 billion valuation, Skydio on its Series F valuation, and CompaniesMarketCap’s Palantir revenue reference.
In our defense tech market deck, we identify pain points entrepreneurs should prioritize
Related blog posts
- How's Anduril doing these days?
- Which companies have raised the most funding in defense tech?
- Which companies are the most valued in defense tech?
- Is the Defense Tech Market growing now?
